ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ATNM Actinium Pharmaceuticals Inc

5.45
0.15 (2.83%)
Dec 08 2023 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 23k940k45k45k0000
Operating Income -8.05M-5.16M-7.85M-9.8M-11.29M-11.58M-15.64M-14.35M
Pre Tax Income -8.01M-5.13M-7.77M-9.47M-10.65M-11.04M-15.18M-13.28M
Net Income -8.01M-5.13M-7.77M-9.47M-10.65M-11.04M-15.18M-13.28M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -8.05M-5.16M-7.85M-9.8M-11.29M-11.58M-15.64M-14.35M
EBITDA -7.91M-5.03M-7.67M-9.58M-11.13M-11.4M-15.43M-14.15M
Year End December 30 2022 20152016201720182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000001.14M1.03M
Operating Income -24.83M-26.85M-26.91M-23.83M-22.07M-22.39M-24.96M-34.1M
Pre Tax Income -21.03M-24.32M-26.6M-23.65M-21.9M-22.22M-24.77M-33.02M
Net Income -21.03M-24.32M-26.6M-23.65M-21.9M-22.22M-24.77M-33.02M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.702-0.436-0.332-0.204-0.133-1.154-1.119-1.286
EBIT -24.83M-26.85M-26.91M-23.83M-22.07M-22.39M-24.96M-34.1M
EBITDA -24.78M-26.77M-26.85M-23.78M-22.02M-21.95M-24.44M-33.41M

Your Recent History

Delayed Upgrade Clock